The largest database of trusted experimental protocols

Cremophor

Cremophor is a nonionic solubilizing agent and emulsifier commonly used in pharmaceutical formulations to enhance the solubility and bioavailability of hydrophobic drugs.
It is a polyethoxylated castor oil derivative that can form micelles to solubilize poorly water-soluble compounds.
Cremophor has been widely studied for its potential applications in drug delivery, particularly in the development of nanomedicines and parenteral formulations.
Researchers can optimize Cremophor-based research with the help of PubCompare.ai's AI-driven protocol comparisons, which can identify the most reproducible and accurate procedures from literature, preprints, and patents.
This intuitive, data-driven tool can also help scientists locate the best Cremophor products and procedures to enhance their research.

Most cited protocols related to «Cremophor»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Allodynia AM 630 AM 1710 Animals antagonists Cardiac Arrest CCL2 protein, human Chemokine Common Cold cremophor Cytokine Endocannabinoids fatty acid amide hydrolase Genotype Inflammation Interleukin-1 beta Mice, Inbred C57BL Monoacylglycerol Lipases Mus Opioid Receptor Paclitaxel Receptor, Cannabinoid, CB1 Receptor, Cannabinoid, CB2 Rectum Rimonabant RNA, Messenger Tumor Necrosis Factor-alpha Withdrawal Symptoms
This study was approved by the Temple University Animal Care and Use Committee and was conducted in a manner that does not inflict unnecessary pain or discomfort upon the animal, as outlined by the United States Public Health Service Policy on Humane Care and Use of Laboratory Animals and the Guide for the Care and Use of Laboratory Animals. Twenty-six male and 120 female C57Bl/6 mice (ACE Animals, Boyertown, PA) were group housed under a reverse 12-hour light/dark cycle with ad libitum access to food and water. Mice were treated with paclitaxel (1.0 to 8.0 mg/kg IP), Cremophor vehicle (ETOH: Cremophor: saline in a 1:1:18 ratio), or saline on a standard dosing regimen of days 1, 3, 5, and 7. CBD-treated mice (5.0 or 10.0 mg/kg IP) or controls (Cremophor vehicle) were also injected once daily on days 1 to 14. The acetone drop test4 (link) and Von Frey filament assay5 were used to assess cold and mechanical allodynia, respectively. Baseline responses in each assay were determined on separate days before administration of paclitaxel. Subsequent behavioral testing was performed every 3 to 10 days after the start of drug dosing. Briefly, mice were placed inside ventilated polycarbonate chambers on an aluminum mesh table. For assessment of cold allodynia, 0.05 mL of acetone was projected via a needle and syringe onto the plantar surface of the right hindpaw, and time spent attending to the paw was recorded for 60 seconds. For assessment of mechanical allodynia, von Frey filaments ranging from 0.16 to 6 g bending force were applied to the plantar skin of the right hindpaw, and each application was held for 6 seconds, using the up–down method to determine threshold sensitivity. Two-way (GraphPad Prism 4.0) analysis of variance (ANOVA) with the factors of Treatment and Time were used to examine the effect of paclitaxel and CBD treatment within a sex. Three-way (PASW Statistics 18.0) ANOVAs with factors of Treatment, Time, and Sex were used to examine the effect of paclitaxel between sexes.
Publication 2011
Acetone Allodynia Aluminum Animals Animals, Laboratory ARID1A protein, human Biological Assay Common Cold cremophor Cytoskeletal Filaments Ethanol Females Food Gender G Force Hypersensitivity Males Mechanical Allodynia Mice, House Mice, Inbred C57BL Needles Neoplasm Metastasis neuro-oncological ventral antigen 2, human Paclitaxel Pain Pharmaceutical Preparations polycarbonate prisma Saline Solution Skin Syringes Treatment Protocols

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2016
Caimans Cannabis sativa Complex Extracts cremophor EL Drug Abuse Ethanol Inclusion Bodies Inhalation Inhalation Exposure Injections, Intraperitoneal Pharmaceutical Preparations Propylene Glycol Saline Solution SR141716 Temperature Regulations, Body Vacuum
Clozapine was provided as a generous gift to J.H.P. from Novartis (Hanover, NJ, USA). Olanzapine was provided as a generous gift to J.H.P. from Eli Lilly (Indianapolis, IN, USA). Clozapine, olanzapine, and risperidone were supplied to D.W. by the National Institute of Mental Health’s Chemical Synthesis and Drug Supply Program. Haloperidol, prazosin, propranolol, and ritanserin were purchased from Sigma-Aldrich (St. Louis, MO, USA). J.H.P. and M.S.F. obtained CNO from the Rapid Access to Investigative Drug Program funded by the National Institute of Neurological Disorders and Stroke. D.W. obtained CNO from the National Institute on Drug Abuse Drug Supply Program.
Clozapine, olanzapine, risperidone, haloperidol, prazosin, propranolol, and ritanserin were each dissolved in distilled water with 2–3 drops of lactic acid and pH-adjusted to 6.0–7.0 with NaOH. For mouse drug discrimination studies, CNO was also dissolved in this vehicle. For rat drug discrimination studies and for mouse and rat pharmacokinetic analyses, CNO was dissolved in bacteriostatic saline containing v/v 2.5–5.0% dimethyl sulfoxide (Sigma-Aldrich) and 10% Cremophor EL (Sigma-Aldrich).
For mouse drug discrimination studies, all drugs were administered s.c. at a volume of 10 ml/kg, 30 min prior to session onset. For rat drug discrimination studies, all drugs were administered i.p. at a volume of 1 ml/kg. Clozapine was administered 60 min prior to session onset, while olanzapine, risperidone, prazosin, and propranolol were administered 30 min prior to session onset. CNO was tested at both 30 and 60 min pretreatment times. All drug doses are expressed as the salt weight.
Full text: Click here
Publication 2018
Anabolism Clozapine cremophor EL Discrimination, Psychology Haloperidol Lactic Acid Mice, House Olanzapine Pharmaceutical Preparations Prazosin Propranolol Risperidone Ritanserin Saline Solution Sodium Chloride Sulfoxide, Dimethyl
Paclitaxel (Tocris, Bristol, UK) was dissolved in a solution made up of 50% Cremophor EL and 50% absolute ethanol to a concentration of 6 mg/ml and stored at −20°C for a maximum of 14 days. It was then diluted in normal saline (NaCl 0.9%) to a final concentration of 0.2 mg/ml just before administration. The vehicle for paclitaxel was diluted at the time of injection with normal saline in the same proportion as the paclitaxel solution. Paclitaxel 2 mg/kg or its vehicle were administered to the mice intraperitoneally, in a volume of 10 ml/kg, once per day for 5 consecutive days. This treatment regimen has been reported to produce painful neuropathy in mice [6 (link)].
COL-3 (a gift from Galderma, Research and Development SNC, Les Templier, France) was dissolved in 1% methylcellulose and administered to mice by oral gavage in a volume of 12.5 ml/kg body mass. COL-3 (4–40 mg/kg) was coadministered with paclitaxel or its vehicle daily for 5 days. The mice were assessed for the development of neuropathic pain (thermal hyperalgesia) and those that received paclitaxel plus COL-3 were compared with the mice treated with the paclitaxel plus vehicle (for COL-3) only.
Reaction latencies to the hot plate test were measured before treatment (baseline latency) and on days 7, 10, 14, 17, 21 and 28 after the first injection of drugs (paclitaxel or COL-3). Briefly, the mice were individually placed on a hot plate (Panlab SL, Barcelona, Spain) with the temperature adjusted to 55 ± 1°C. The time to the first sign of nociception, paw licking, flinching or jump response to avoid the heat was recorded and the animal immediately removed from the hot plate. A cutoff period of 20 s was maintained to avoid damage to the paws. The observer (S.S.P.) was blinded to the treatment the animal received. The percentage change in reaction latency was calculated as follows: [(response latency after drug treatment – pretreatment baseline latency)/pretreatment baseline latency] ×100.
Publication 2012
Animals COL-3 cremophor EL Ethanol Human Body Hyperalgesia, Thermal Methylcellulose Mice, House Neuralgia Neuropathy, Painful Nociception Normal Saline Paclitaxel Pharmaceutical Preparations Sodium Chloride Treatment Protocols Tube Feeding

Most recents protocols related to «Cremophor»

Furosemide, lipase, minimum essential medium, oleic acid, Tween 80®, Tween 20®, polyethylene glycol, and glycerol were purchased from Sigma Aldrich (St. Louis, MO, USA). Gattefossé, Neuilly sur-Seine, France, gifted Cremophor EL®, Transcutol HP®, and Cremophor RH 40®. All other reagents used were of analytical grade.
Full text: Click here
Publication 2024
SMM-189 was provided by Dr. Bob Moore II and formulated with 15% ethanol (v/v), 15% cremophor (w/v) and 70% saline (v/v). In brief, SMM-189 was dissolved in 15% ethanol, cremophor was weighed in a separate vial and dissolved SMM-189 slowly added and mixed gently until combined. Saline was slowly added and mixed until achieving a homogenous solution. The final solution was sterile filtered with a syringe 0.22μm filter and stored at 4°C in amber sterile-glass vials for up to 2 weeks. Vehicle treatments consisted of the same concentrations of ethanol, cremophor and saline. Daily injections were administered by research staff blinded to cohort treatment history.
Full text: Click here
Publication Preprint 2024

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2024
Madin-Darby canine kidney cells (MDCK) were obtained from Korean Cell Line Bank (KCLB, Seoul, Korea). MDCK cells were cultured in Dulbecco Modified Eagle Medium (DMEM) with 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA) at 37 °C with 5% CO2. For the cyclosporine toxicity model, Cells were treated with 20 uM of CSA contained with vehicle polyoxyethylated caster oil (Cremophor EL, Sigma Aldrich, St. Louis, MO, USA) Vehicle (Cremophor EL, Sigma) equivalent to the 20 uM was used as control.
Full text: Click here
Publication 2024
Solubility studies of FSM in various oils (soybean oil, sunflower oil, castor oil, oleic acid, and sesame oil), surfactant (Cremophor EL, Cremophor RH 40, Tween 80, Tween 20), and co-surfactants (Propylene glycol, Glycerol, PEG 400, and Transcutol HP) were assessed. µ Afterwards, vials were centrifuged at 2000 rcf for 10 min, and the supernatant was collected. 100 µL of supernatant was dissolved in 1900 µL of 0.1 M NaOH, and the amount of dissolved FSM was measured using a UV-spectrophotometer at 274 nm [32 (link)].
Full text: Click here
Publication 2024

Top products related to «Cremophor»

Sourced in United States, Germany, United Kingdom, Japan, Macao, Spain, Israel, France, Brazil, India, Austria
Cremophor EL is a nonionic surfactant used as a solubilizing agent in pharmaceutical and cosmetic formulations. It is a polyoxyethylene castor oil derivative that increases the solubility of hydrophobic compounds in aqueous solutions. Cremophor EL is commonly used in various drug delivery systems to improve the solubility and bioavailability of poorly water-soluble drugs.
Sourced in United States, Brazil, Germany, United Kingdom, Israel, Sao Tome and Principe
Cremophor is a solubilizing agent used in the formulation of pharmaceutical products. It is a non-ionic surfactant derived from castor oil and polyethylene glycol. Cremophor is commonly used to increase the solubility and bioavailability of poorly water-soluble drugs.
Sourced in Germany, United Kingdom, India, United States, China
Cremophor EL is a non-ionic surfactant derived from castor oil. It is commonly used as an emulsifier and solubilizer in pharmaceutical and cosmetic formulations.
Sourced in Germany, India, United States, France
Cremophor RH40 is a non-ionic solubilizer and emulsifier. It is a polyoxethylene hydrogenated castor oil. Cremophor RH40 is used to solubilize and emulsify various ingredients in pharmaceutical, cosmetic, and industrial applications.
Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, Macao, India, Canada, Switzerland, Japan, Australia, Spain, Poland, Belgium, Brazil, Czechia, Portugal, Austria, Denmark, Israel, Sweden, Ireland, Hungary, Mexico, Netherlands, Singapore, Indonesia, Slovakia, Cameroon, Norway, Thailand, Chile, Finland, Malaysia, Latvia, New Zealand, Hong Kong, Pakistan, Uruguay, Bangladesh
DMSO is a versatile organic solvent commonly used in laboratory settings. It has a high boiling point, low viscosity, and the ability to dissolve a wide range of polar and non-polar compounds. DMSO's core function is as a solvent, allowing for the effective dissolution and handling of various chemical substances during research and experimentation.
Sourced in United States, Germany, United Kingdom, India, Italy, France, Sao Tome and Principe, Spain, Poland, China, Belgium, Brazil, Switzerland, Canada, Australia, Macao, Ireland, Chile, Pakistan, Japan, Denmark, Malaysia, Indonesia, Israel, Saudi Arabia, Thailand, Bangladesh, Croatia, Mexico, Portugal, Austria, Puerto Rico, Czechia
Tween 80 is a non-ionic surfactant and emulsifier. It is a viscous, yellow liquid that is commonly used in laboratory settings to solubilize and stabilize various compounds and formulations.
Sourced in France, India, United States, Germany, Canada, China
Labrasol is a non-ionic surfactant used in various pharmaceutical and cosmetic applications. It is a polyoxyethylene glycerol fatty acid ester that acts as a solubilizer, emulsifier, and wetting agent. Labrasol is designed to improve the solubility and bioavailability of active ingredients in formulations.
Sourced in United States, Germany, United Kingdom, France, China, Macao, Japan, Sao Tome and Principe, Canada, Poland, Spain, Israel, Australia, Switzerland, Italy
Paclitaxel is a pharmaceutical compound used in the production of various cancer treatment medications. It functions as a microtubule-stabilizing agent, which plays a crucial role in the development and regulation of cells. Paclitaxel is a key ingredient in the manufacture of certain anti-cancer drugs.
Sourced in France, India, Germany, United States
Transcutol HP is a high-purity, pharmaceutical-grade solvent used in various formulations. It serves as a solubilizer, humectant, and penetration enhancer to facilitate the delivery of active ingredients through the skin.
Sourced in France, India
Capryol 90 is an oily, clear liquid that serves as a solubilizing and emulsifying agent for use in pharmaceutical and cosmetic formulations.

More about "Cremophor"

Cremophor is a versatile nonionic solubilizing agent and emulsifier that plays a crucial role in pharmaceutical formulations.
This polyethoxylated castor oil derivative can enhance the solubility and bioavailability of hydrophobic drugs by forming micelles to solubilize poorly water-soluble compounds.
Cremophor EL, Cremophor RH40, and other Cremophor variants have been extensively studied for their potential applications in drug delivery, particularly in the development of nanomedicines and parenteral formulations.
Researchers can optimize their Cremophor-based research by utilizing AI-driven protocol comparisons from PubCompare.ai, which can identify the most reproducible and accurate procedures from literature, preprints, and patents.
In addition to Cremophor, other excipients like DMSO, Tween 80, Labrasol, and Transcutol HP are often used in conjunction with Cremophor to enhance drug solubility and delivery.
For example, Paclitaxel, a widely used anticancer drug, has been formulated with Cremophor to improve its aqueous solubility and bioavailability.
PubCompare.ai's intuitive, data-driven tool can help scientists locate the best Cremophor products and procedures to enhance their research, leading to more reproducible and accurate results.
With the help of this AI-powered platform, researchers can optimize their Cremophor-based studies and drive innovation in the field of pharmaceutical science.